Trial of OncoVeryx© for Early Detection of Cancer and Prediction of Tissue of Origi
- Conditions
- Health Condition 1: R978- Other abnormal tumor markers
- Registration Number
- CTRI/2024/06/068780
- Lead Sponsor
- MS Clinfinite Solutions
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Subjects who voluntarily participate in this study by signing their Informed Consent Form
(ICF) in the local language prior to any study-mandated procedure.
2. Males or females aged = 18 years at time of signing the ICF.
3. Group 1:
i. Subjects who are diagnosed with or suspected to have any cancer type.
ii. Subjects must be treatment naive [i.e., should not have history of any chemotherapy, immunotherapy, radiotherapy etc.,].
1. Currently participating in another investigational study.
2. Female subjects who are pregnant
3. Subjects with either high-grade dysplasia, autoimmune disease, or chronic kidney disease.
4. Subjects has a condition that, in the opinion of the investigator, would preclude participation in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method